Health Condition 1: null- clinical or biochemical suspicion of prostate carcinoma
Conditions
Interventions
Intervention1: Addition of diltiazem to para prostatic nerve block: patient will recieve both para prostatic nerve block and application of diltiazem. Nerve block will be given by 1% lignocaine on ri
Sponsors
Dr Tarun Jindal
Eligibility
Inclusion criteria
Inclusion criteria: The patients who were to have their first prostatic biopsy due to clinical or biochemical suspicion of carcinoma prostate were included in the trial.
Exclusion criteria
Exclusion criteria: history of active anal diseases, anal fissures, haemorrhoids, rectal ulcers, chronic pelvic pain syndrome, prostodynia, active urinary tract infection, coagulopathies, neuropathies, uncontrolled diabetes, ingestion of asprin or clopidogril or any other antiplatelet drugs, use of narcotics and analgesics, antihypertensive medications, known allergy to diltiazem or lignocaine, low systolic blood pressure ( <100 mm Hg), severe renal, cardiac or hepatic illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the decrease in the pain score during prostate biopsy by the addition of diltiazem cream, applied intra and perirectaly.Timepoint: the pain score assessment will be done at the time of insertion of probe in the rectum and again at the the time of prostate biopsy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Any complications due to the addition of diltiazem cream during and after prostate biopsyTimepoint: the complications occuring within 2 hours of the procedure will be noted. the patients will also be followed for one week to note delayed complications. | — |
Countries
India
Contacts
Public ContactTarun Jindal
Calcutta National Medical College
Outcome results
None listed